foryourhealth111-pixel/Vibe-Skills / bundled/skills/clinical-reports
clinical-reports
VerifiedWrite comprehensive clinical reports including case reports (CARE guidelines), diagnostic reports (radiology/pathology/lab), clinical trial reports (ICH-E3, SAE, CSR), and patient documentation (SOAP, H&P, discharge summaries). Full support with templates, regulatory compliance (HIPAA, FDA, ICH-GCP), and validation tools.
assets/clinical_trial_sae_template.md
View on GitHub# Serious Adverse Event (SAE) Report Template
## Report Information
**Report Type:** [ ] Initial Report [ ] Follow-up Report [ ] Final Report
**Report Number:** [SAE-YYYY-####]
**Report Date:** [MM/DD/YYYY]
**Reporter:** [Name and title]
**Reporter Contact:** [Email and phone]
**Follow-up Number:** [If follow-up: #1, #2, etc.]
**Previous Report Date:** [If follow-up]
---
## Study Information
**Protocol Number:** [Protocol ID]
**Protocol Title:** [Full study title]
**Study Phase:** [ ] Phase I [ ] Phase II [ ] Phase III [ ] Phase IV
**Study Sponsor:** [Sponsor name]
**IND/IDE Number:** [IND or IDE number if applicable]
**ClinicalTrials.gov ID:** [NCT number]
**Principal Investigator:** [Name]
**Site Number:** [Site ID]
**Site Name:** [Institution name]
---
## Subject Information (De-identified)
**Subject ID / Randomization Number:** [ID only, no name]
**Subject Initials:** [XX] (if permitted by regulatory authority)
**Age:** [Years] OR **Date of Birth:** [Year only: YYYY]
**Sex:** [ ] Male [ ] Female [ ] Other
**Race:** [Category]
**Ethnicity:** [Hispanic or Latino / Not Hispanic or Latino]
**Weight:** [kg]
**Height:** [cm]
**Study Arm / Treatment Group:** [ ] Treatment A [ ] Treatment B [ ] Placebo [ ] Blinded
**Date of Informed Consent:** [MM/DD/YYYY]
**Date of First Study Drug:** [MM/DD/YYYY]
**Date of Last Study Drug:** [MM/DD/YYYY]
**Study Drug Status at Time of Event:** [ ] Ongoing [ ] Completed [ ] Discontinued
---
## Adverse Event Information
**Reported Term (Verbatim):** [Exact term reported by investigator/patient]
**MedDRA Coding:**
- **Preferred Term (PT):** [MedDRA PT]
- **System Organ Class (SOC):** [MedDRA SOC]
- **MedDRA Version:** [e.g., 25.0]
**Event Description:**
[Detailed narrative description of the adverse event]
**Date of Onset:** [MM/DD/YYYY]
**Time of Onset:** [HH:MM] (if known and relevant)
**Date of Resolution:** [MM/DD/YYYY] OR [ ] Ongoing
**Duration:** [Days/hours if resolved]
**Event Location:** [ ] Inpatient [ ] Outpatient [ ] Home [ ] Other: ________
---
## Seriousness Criteria
**This event is considered serious because it resulted in or required:**
- [ ] **Death** - Date of death: [MM/DD/YYYY]
- [ ] **Life-threatening** - Immediate risk of death at time of event
- [ ] **Hospitalization (initial or prolonged)** - Dates: [MM/DD/YYYY to MM/DD/YYYY]
- [ ] **Persistent or significant disability/incapacity**
- [ ] **Congenital anomaly/birth defect**
- [ ] **Medically important event** - Explanation: _________________
**Hospitalization Details (if applicable):**
- Admission Date: [MM/DD/YYYY]
- Discharge Date: [MM/DD/YYYY] OR [ ] Still hospitalized
- Hospital Name: [Name and location]
- ICU Admission: [ ] Yes [ ] No
- If yes, dates: [MM/DD/YYYY to MM/DD/YYYY]
---
## Severity Assessment
**Severity (Intensity):**
- [ ] **Mild** - Noticeable but does not interfere with daily activities
- [ ] **Moderate** - Interferes with daily activities but manageable
- [ ] **Severe** - Prevents usual daily activities, requires intervention
*Note: Severity is not the same as seriousness*
---
## Outcome
- [ ] **Recovered/Resolved** - Complete resolution, returned to baseline
- [ ] **Recovering/Resolving** - Improving but not yet fully resolved
- [ ] **Not Recovered/Not Resolved** - Ongoing without improvement
- [ ] **Recovered/Resolved with Sequelae** - Persistent effects remain
- [ ] **Fatal** - Event resulted in death
- [ ] **Unknown** - Unable to determine outcome
**Date of Final Outcome (if resolved):** [MM/DD/YYYY]
---
## Causality Assessment
**Relationship to Study Drug:**
- [ ] **Not Related** - Clearly due to other cause
- [ ] **Unlikely Related** - Doubtful connection to study drug
- [ ] **Possibly Related** - Could be related, but other causes possible
- [ ] **Probably Related** - More likely related to study drug than other causes
- [ ] **Definitely Related** - Certain relationship to study drug
**Relationship to Study Procedures:**
- [ ] Not Related [ ] Unlikely [ ] Possibly [ ] Probably [ ] Definitely
**Relationship to Underlying Disease:**
- [ ] Not Related [ ] Unlikely [ ] Possibly [ ] Probably [ ] Definitely
**Relationship to Concomitant Medications:**
- [ ] Not Related [ ] Unlikely [ ] Possibly [ ] Probably [ ] Definitely
- Suspected medication(s): _____________________
**Rationale for Causality Assessment:**
[Detailed explanation of causality determination, including temporal relationship, biological plausibility, dechallenge/rechallenge if applicable, alternative explanations]
---
## Expectedness
**Is this event expected based on the Investigator's Brochure or protocol?**
- [ ] **Expected** - Listed in IB/protocol with similar characteristics
- [ ] **Unexpected** - Not listed OR more severe than documented
**Reference:** [IB version and section, or protocol section]
---
## Action Taken with Study Drug
- [ ] **No change** - Study drug continued at same dose
- [ ] **Dose reduced** - New dose: ______ (from ______)
- [ ] **Dose increased** - New dose: ______ (from ______)
- [ ] **Drug interrupted** - Dates: [MM/DD to MM/DD]
- [ ] Resumed [ ] Not resumed
- [ ] **Drug permanently discontinued** - Date: [MM/DD/YYYY]
- [ ] **Not applicable** - Event occurred after study drug discontinued
**Dechallenge:** [ ] Positive (improved after stopping) [ ] Negative [ ] Not done
**Rechallenge:** [ ] Positive (recurred after restarting) [ ] Negative [ ] Not done
---
## Treatment and Interventions
**Treatments Given for This Event:**
1. **[Medication/Procedure]**
- Dose/Details: _________________
- Route: _________________
- Start Date: [MM/DD/YYYY]
- Stop Date: [MM/DD/YYYY] OR [ ] Ongoing
- Response: [ ] Effective [ ] Partially effective [ ] Not effective
2. **[Additional treatments]**
**Hospitalization Interventions:**
- [ ] IV fluids
- [ ] Oxygen therapy
- [ ] Mechanical ventilation
- [ ] Surgical intervention - Procedure: ______________
- [ ] ICU care
- [ ] Other: ______________
---
## Relevant Medical History
**Pre-existing Conditions Relevant to This Event:**
[List conditions that may be related to the event]
**Concomitant Medications at Time of Event:**
| Medication | Indication | Dose/Frequency | Start Date | Stop Date |
|------------|-----------|----------------|------------|-----------|
| [Name] | [Indication] | [Dose] | [MM/DD/YYYY] | [MM/DD/YYYY or Ongoing] |
---
## Laboratory and Diagnostic Tests
**Relevant Laboratory Values:**
| Test | Result | Units | Reference Range | Date | Relation to Event |
|------|--------|-------|----------------|------|-------------------|
| [Test] | [Value] | [Units] | [Range] | [MM/DD] | [Before/During/After] |
**Imaging/Diagnostic Studies:**
- **[Study type] ([Date]):** [Key findings]
**ECG/Monitoring:**
[Results if relevant]
---
## Detailed Event Narrative
[Comprehensive chronological narrative of the event]
**Minimum elements to include:**
- Patient demographics and study participation timeline
- Relevant medical history
- Chronological description of event development
- Symptoms, signs, and clinical course
- Diagnostic workup and results
- Treatments administered and response
- Clinical outcome and current status
- Investigator's assessment of causality and reasoning
**Example Structure:**
```
A [age]-year-old [sex] with a history of [relevant medical conditions] enrolled in
Study [protocol] on [date] and was randomized to [treatment arm]. The patient had
been receiving [study drug] at [dose] for [duration] when, on [date], the patient
developed [initial symptoms].
[Describe progression of symptoms, timeline, clinical findings...]
[Describe diagnostic workup performed and results...]
[Describe treatments given and patient response...]
[Describe outcome and current status...]
The investigator assessed this event as [causality] related to study drug because
[reasoning]. Alternative explanations include [list alternative causes considered].
```
---
## Investigator Assessment
**Investigator's Comments:**
[Additional relevant information, clinical interpretation, conclusions]
**Does this event meet criteria for expedited reporting to regulatory authorities?**
- [ ] Yes - Fatal or life-threatening unexpected SAE
- [ ] Yes - Other unexpected SAE
- [ ] No - Expected event
---
## Follow-up Information Required
**Information Pending (if initial or follow-up report):**
- [ ] Final outcome
- [ ] Laboratory results
- [ ] Pathology report
- [ ] Imaging results
- [ ] Autopsy results (if death)
- [ ] Consultant reports
- [ ] Medical records
- [ ] Dechallenge/rechallenge information
- [ ] Other: ______________
**Expected Date for Follow-up Report:** [MM/DD/YYYY]
---
## Regulatory Reporting
**Sponsor Safety Assessment:**
[To be completed by sponsor]
- Expectedness: [ ] Expected [ ] Unexpected
- Relationship: [ ] Related [ ] Not related
- Reportable to FDA/EMA: [ ] Yes [ ] No
- Timeline: [ ] 7-day [ ] 15-day [ ] Annual
**IRB Notification:**
- Reported to IRB: [ ] Yes [ ] No [ ] Not required
- Date reported: [MM/DD/YYYY]
- IRB determination: _______________
---
## Signatures
**Investigator Signature:**
**Name:** [Principal Investigator name]
**Title:** [MD, credentials]
**Signature:** ____________________
**Date:** [MM/DD/YYYY]
**I certify that this report is accurate and complete to the best of my knowledge.**
---
**Sponsor Representative (if applicable):**
**Name:** [Name]
**Title:** [Medical Monitor, Safety Officer]
**Signature:** ____________________
**Date:** [MM/DD/YYYY]
---
## Attachments
- [ ] Relevant laboratory reports
- [ ] Imaging reports
- [ ] Pathology reports
- [ ] Discharge summary
- [ ] Death certificate (if applicable)
- [ ] Autopsy report (if applicable)
- [ ] Consultant notes
- [ ] Other: ______________
---
## Distribution List
- [ ] Study Sponsor
- [ ] FDA (if applicable)
- [ ] IRB/IEC
- [ ] Data Safety Monitoring Board (if applicable)
- [ ] Site regulatory files
---
## Notes
**Regulatory Timeline Requirements:**
- **Fatal or life-threatening unexpected SAEs:** 7 days for preliminary report, 15 days for complete
- **Other serious unexpected events:** 15 days
- **IRB notification:** Per institutional policy (typically 5-10 days)
**Key Points:**
- Complete all sections accurately
- Provide detailed narrative
- Include temporal relationships
- Document all sources of information
- Follow up until event resolved
- Maintain patient confidentiality
- Use only de-identified information
Related skills
| Skill | Stars | Updated | Works with | Status | Install |
|---|---|---|---|---|---|
| writing-skillsobra/superpowersUse when creating new skills, editing existing skills, or verifying skills work before deployment | Stars: 323k | Updated | Claude CodeCodex | Verified | Install |
| xlsxanthropics/skillsUse this skill any time a spreadsheet file is the primary input or output. This means any task where the user wants to: open, read, edit, or fix an existing .xlsx, .xlsm, .xltx, .csv, or .tsv file (e.g., adding columns, computing formulas, formatting, charting, cleaning messy data); create a new spreadsheet from scratch or from other data sources; or convert between tabular file formats. Trigger especially when the user references a spreadsheet file by name or path — even casually (like "the xlsx in my downloads") — and wants something done to it or produced from it. Also trigger for cleaning or restructuring messy tabular data files (malformed rows, misplaced headers, junk data) into proper spreadsheets. The deliverable must be a spreadsheet file. Do NOT trigger when the primary deliverable is a Word document, HTML report, standalone Python script, database pipeline, or Google Sheets API integration, even if tabular data is involved. | Stars: 198k | Updated | Claude CodeCodex | Verified | Install |
| shipping-and-launchaddyosmani/agent-skillsPrepares production launches. Use when preparing to deploy to production, or when asking what needs to be in place before shipping. Use when you need a pre-launch checklist, when setting up monitoring, when planning a staged rollout, or when you need a rollback strategy. | Stars: 119k | Updated | Claude CodeCodex | Verified | Install |
| childhoodthedotmack/claude-memBabysit a shipped release after merge, publication, or deployment. Verify published packages, production behavior, installed plugins, and late CI or user reports until the observation window is clean; use babysit for PR readiness before release. | Stars: 118k | Updated | Claude CodeCodex | Verified | Install |